ArticleOncoimmunology

Impact of PD-L1 expression, driver mutations and clinical characteristics on survival after anti-PD-1/PD-L1 immunotherapy versus chemotherapy in non-small-cell lung cancer: A meta-analysis of randomized trials.

Qingyuan Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.